AUPH · Aurinia Pharmaceuticals Inc.
Market Cap
$2.17B
Shares
133.05M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-19 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-06-04 | 2026-06-03 | |
| 8-K | 2026-05-11 | 2026-05-08 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-21 | 2026-06-03 | |
| 8-K | 2026-04-03 | 2026-03-30 | |
| 8-K | 2026-03-23 | 2026-03-20 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2025-11-04 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-07-31 | — | |
| 10-Q | 2025-07-31 | 2025-06-30 | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-05-15 | — | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| DEF 14A | 2025-04-17 | 2025-05-15 | |
| 8-K | 2025-02-27 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-09-12 | 2024-09-09 | |
| 8-K | 2024-08-01 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-06-14 | — | |
| DEF 14A | 2024-05-03 | 2024-06-14 | |
| 8-K | 2024-05-02 | — | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| 10-K/A | 2024-04-29 | 2023-12-31 | |
| 8-K | 2024-02-29 | 2024-02-27 | |
| 8-K | 2024-02-15 | — | |
| 10-K | 2024-02-15 | 2023-12-31 | |
| 8-K | 2024-01-05 | — | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 8-K | 2023-09-21 | — | |
| 8-K | 2023-08-21 | 2023-08-18 | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-07-03 | 2023-06-29 | |
| 8-K | 2023-05-17 | — | |
| 10-Q | 2023-05-04 | 2023-03-31 | |
| 8-K | 2023-05-04 | — | |
| DEF 14A | 2023-04-18 | 0001-01-01 | |
| 8-K | 2023-04-05 | — | |
| 8-K | 2023-03-13 | — |
Showing 1–50 of 124 filings
Key facts
CIK
1600620
CUSIP
05156V102
13F (30d)
223 filings
222 filers
Visit website
Investor relations